Improved Dissolution Properties of Co-amorphous Probucol with Atorvastatin Calcium Trihydrate Prepared by Spray-Drying

被引:0
作者
Oyama, Shinji [1 ]
Ogawa, Noriko [1 ]
Kawai, Kaori [1 ]
Iwai, Kanako [1 ]
Yasunaga, Toshiya [1 ]
Yamamoto, Hiromitsu [1 ]
机构
[1] Aichi Gakuin Univ, Dept Pharmaceut Engn, Sch Pharm, 1-100 Kusumoto cho,Chikusa ku, Nagoya 4648650, Japan
基金
日本学术振兴会;
关键词
atorvastatin calcium trihydrate salt; co-amorphous; dissolution test; probucol; spray-drying; stability test; SOLID DISPERSION-SYSTEMS; PHYSICAL STABILITY; PHYSICOCHEMICAL PROPERTIES; IN-VITRO; BIOAVAILABILITY; CRYSTALLINE; SOLUBILITY; CLASSIFICATION; NANOPARTICLES; TECHNOLOGIES;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A co-amorphous model drug was prepared by the spray-drying (SD) of probucol (PC) and atorvastatin calcium trihydrate salt (ATO) as low water solubility and co-former components, respectively. The physicochemical properties of the prepared samples were characterized by powder X-ray diffraction (PXRD) analysis, thermal analysis, Fourier transform infrared spectroscopy (FTIR), and dissolution tests. Stability tests were also conducted under a stress environment of 40 degrees C and 75% relative humidity. The results of PXRD measurements and thermal analysis suggested that PC and ATO form a co-amorphous system by SD. Thermal analysis also indicated an endothermic peak that followed an exotherm in amorphous PC and a physical mixture ( PM) of amorphous PC and ATO; however, no endothermic peak was detected in the co-amorphous system. The dissolution profiles for PC in the co-amorphous sample composed of PC and ATO were improved compared to those for raw PC crystals or the PM. Stability tests indicated that the co-amorphous material formed by PC and ATO can be stored for 35 d without crystallization, whereas amorphous PC became crystallized within a day. Therefore, co-amorphization of PC and ATO prepared by SD is considered to be a useful method to improve the solubility of PC in water.
引用
收藏
页码:190 / 199
页数:10
相关论文
共 49 条
[1]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[2]  
[Anonymous], 1994, NOT GUID TOX ASS SYS
[3]  
BARNHART RL, 1989, J LIPID RES, V30, P1703
[4]   Amorphous solid dispersions and nano-crystal technologies for poorly water-soluble drug delivery [J].
Brough, Chris ;
Williams, R. O., III .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 453 (01) :157-166
[5]   Formulation of a Danazol Cocrystal with Controlled Supersaturation Plays an Essential Role in Improving Bioavailability [J].
Childs, Scott L. ;
Kandi, Praveen ;
Lingireddy, Sreenivas Reddy .
MOLECULAR PHARMACEUTICS, 2013, 10 (08) :3112-3127
[6]   Prediction of Solubility and Permeability Class Membership: Provisional BCS Classification of the World's Top Oral Drugs [J].
Dahan, Arik ;
Miller, Jonathan M. ;
Amidon, Gordon L. .
AAPS JOURNAL, 2009, 11 (04) :740-746
[7]   Bridging solubility between drug discovery and development [J].
Di, Li ;
Fish, Paul V. ;
Mano, Takashi .
DRUG DISCOVERY TODAY, 2012, 17 (9-10) :486-495
[8]   Drug-Like Property Concepts in Pharmaceutical Design [J].
Di, Li ;
Kerns, Edward H. ;
Carter, Guy T. .
CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (19) :2184-2194
[9]   Probucol and atorvastatin in combination protect rat brains in MCAO model: Upregulating Peroxiredoxin2, Foxo3a and Nrf2 expression [J].
Du, Yuanyuan ;
Zhang, Xiangjian ;
Ji, Hui ;
Liu, Haichao ;
Li, Shuya ;
Li, Litao .
NEUROSCIENCE LETTERS, 2012, 509 (02) :110-115
[10]   Simultaneous determination of ezetimibe, atorvastatin and simvastatin using quadrupole LC-MS: Application to combined tablets and plasma after SPE [J].
Elawady, Tarek ;
Ibrahim, Fawzia ;
Khedr, Alaa ;
Belal, Fathalla .
ACTA CHROMATOGRAPHICA, 2021, 33 (03) :245-252